Factors that contribute to faecal cyclooxygenase-2 mRNA expression in subjects with colorectal cancer
Open Access
- 9 February 2010
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 102 (5) , 916-921
Abstract
Background: Methods: Results: Conclusion:Keywords
This publication has 27 references indexed in Scilit:
- Fecal Cyclooxygenase 2 Plus Matrix Metalloproteinase 7 mRNA Assays as a Marker for Colorectal Cancer ScreeningCancer Epidemiology, Biomarkers & Prevention, 2009
- Methylation ofTFPI2in Stool DNA: A Potential Novel Biomarker for the Detection of Colorectal CancerCancer Research, 2009
- Detection of colorectal cancer cells from feces using quantitative real‐time RT‐PCR for colorectal cancer diagnosisCancer Science, 2008
- Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancerBritish Journal of Surgery, 2008
- Exfoliated Cells in Stool: A Source for Reverse Transcription-PCR–Based Analysis of Biomarkers of Gastrointestinal CancerCancer Epidemiology, Biomarkers & Prevention, 2008
- Cyclooxygenase-2 overexpression is common in serrated and non-serrated colorectal adenoma, but uncommon in hyperplastic polyp and sessile serrated polyp/adenomaBMC Cancer, 2008
- Cell exfoliation in the human colon: Myth, reality and implications for colorectal cancer screeningInternational Journal of Cancer, 2007
- Normalizing genes for quantitative RT-PCR in differentiating human intestinal epithelial cells and adenocarcinomas of the colonAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2006
- Randomised controlled trial of faecal-occult-blood screening for colorectal cancerThe Lancet, 1996
- Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion moleculeCell, 1989